IGFBP7 anticorps

N° du produit ABIN636653

Détail du produit anti-IGFBP7 anticorps

Antigène: IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IGFBP7 est non-conjugé

Application: Western Blotting (WB), ELISA

Purification: Purified

Immunogène: IGF BP7 antibody was raised in rabbit using highly pure recombinant human IGF-BP7 as the immunogen.

Information d'application

Indications d'application: Optimal conditions should be determined byt he investigator.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized from PBS, pH 7.2.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.

Détails sur IGFBP7

Antigène: IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))

Autre désignation: IGF BP7 (IGFBP7 Produits)

Synonymes: anticorps zgc:85888, anticorps AGM, anticorps FSTL2, anticorps IBP-7, anticorps IGFBP-7, anticorps IGFBP-7v, anticorps IGFBPRP1, anticorps MAC25, anticorps PSF, anticorps RAMSVPS, anticorps TAF, anticorps Fstl2, anticorps Mac25, anticorps insulin like growth factor binding protein 7, anticorps insulin-like growth factor binding protein 7, anticorps IGFBP7, anticorps igfbp7, anticorps Igfbp7

Sujet: IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP7 is expressed in a wide range of normal human tissues and it generally shows reduced expression in cancer cell lines of prostate, breast, colon, and lung origin. It plays a role in skeletal myogenesis by binding to IGF1n a manner that inhibits IGF1nduced differentiation of skeletal myoblasts, without affecting IGF1nduced proliferation.

Poids moléculaire: 26.4 kDa (predicted detection band MW)

Pathways: Growth Factor Binding